This paper argues that increasing resistance to antimicrobials is an important social externality that has not been captured at the level of economic appraisal. The paper explicitly considers reasons why the externality of antimicrobial resistance has not generally been included as a cost in economi
Should the consumption of survivors be included as a cost in cost–utility analysis?
✍ Scribed by John A. Nyman
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 130 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1057-9230
- DOI
- 10.1002/hec.850
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Survivor costs are those costs associated with a treatment because it extends the patient's life. A controversy exists regarding whether survivor consumption costs should be included in cost–utility analyses. The present paper uses this controversy to motivate a general reexamination of what costs to include in cost–utility analyses. Rather than the ad hoc inclusion rules currently used – a causal relationship between the intervention and the costs, and a proscription on double counting – this paper suggests three inclusion principles based on standard welfare economics. Thus, costs should be (1) included if they represent resources that directly produce the utility that is being measured in the denominator of the cost–utility ratio, (2) excluded if they represent resources that produce utility that is not being measured in the denominator, even though the costs are causally associated with the intervention, and (3) included if they represent resources consumed that are causally related to the intervention, but that have no counterveiling utility gains. These principles suggest important changes in how we account for recuperation time and unrelated medical care. They also suggest that survival consumption costs and earnings be excluded from existing cost–utility analyses. Copyright © 2003 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract Image analysis systems are an essential tool in measurements of size of intraparenchymal tumors or lesions in experimental small animal models. Conventional image analysis systems are relatively expensive. We therefore compared the performance of a professional image analysis system wit